Sun Pharma to buy Organon for $11.75B in major portfolio expansion

An Organon sign seen during the fifth China International Import Expo in 2022 in Shanghai. April 27, 2026 02:16 AM EDT DealsPharma Sun Phar­ma to buy Organon for $11.75B in ma­jor port­fo­lio ex­pan­sion Kyle LaHucik Biotech Correspondent In­di­an drug gi­ant Sun Phar­ma has lined up an $11.75 bil­lion ac­qui­si­tion of Organon, a women’s health and biosim­i­lar mak­er spun out of Mer­ck in … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER